Ethylene Oxide as a Biological Reactive Intermediate of Endogenous Origin
Reactive intermediates can be monitored in vivo through their reaction products (adducts) with macromolecules. Sensitive methods, based on gas chromatography/mass spectrometry which permit structural identification and quantification, have been developed for the determination of adducts to hemoglobin (Hb). In studies of exposed animals, occupationally exposed workers and smokers a number of Hb adducts have been observed in unexposed control individuals. Methods for the determination of Hb adducts have, particularly through the use of tandem mass spectrometry, reached a sensitivity permitting studies of adducts from reactive intermediates due to “background exposure”. N-(2-Hydroxethyl)valine (HOEtVal) is one of the background Hb adducts observed. This adduct has been used as a model in studies of sources of background adducts and determinants of their levels.
From the rate of exhalation of ethene by humans and application of a pharmacokinetic model it was concluded that about 70% of the background HOEtVal in non-smokers originates from ethylene oxide (EO) as the metabolite of endogenously produced ethene. Contributions from ethene in urban air or environmental tobacco smoke are relatively small. Smoking of 2 cig./day approximately doubles the background. In twin studies it was shown that the variations in adduct level are partly due to hereditary factors and family traditions. Animal experiments demonstrate a role of intestinal flora and diet (unsaturated fatty acids, selenium), partly due to influences on metabolic rate. Furthermore, an interaction of dietary fat and intestinal flora is indicated.
From the adduct levels measured and knowledge of the identity of the causative reactive intermediate and of the rate constant for adduct formation, the dose of the reactive intermediate could be calculated. The associated cancer risk could then be estimated through the radiation-dose equivalence of the chemical dose determined in mutation experiments in vitro and application of the cancer risk coefficient for radiation. The risk contribution from the endogenous production of EO has been estimated by this approach to be of approximately the same magnitude as the risk due to background radiation.
KeywordsEthylene Oxide Environmental Tobacco Smoke Intestinal Flora Annual Dose Adduct Level
Unable to display preview. Download preview PDF.
- Berlin, N.I., 1964, Life-span of the red cell, In: Bishop, C. and Surgenor, D.M. (eds) The Red Blood Cell Academic Press, New York and London, pp. 423–450.Google Scholar
- Duus, U., Osterman-Golkar, S., Törnqvist, M., Mowrer, J., Holm, S. and Ehrenberg, L., 1989, Studies of determinants of tissue dose and cancer risk from ethylene oxide exposure, In: Freij, L. (ed), Proceedings: Management of Risk from Genotoxic Substances in the Environment, Swedish National Chemicals Inspectorate, Solna, pp. 141–153.Google Scholar
- Ehrenberg, L. and Törnqvist, M., 1995, The research background for risk assessment of ethylene oxide, Mutat. Res. (in press).Google Scholar
- Ehrenberg, L., Granath, F., Hedenskog, M., Magnusson, A.-L., Natarajan, A.T., Tates, A., Törnqvist, M. and Wright A., 1995, Comparisons of ethylene oxide and low-LET radiation. (ms.).Google Scholar
- Eide, I., Hagemann, R., Zahlsen, K., Tareke, E., Törnqvist. M., Kumar, R., Vodicka, P. and Hemminki, K., 1995, Uptake, distribution, and formation of hemoglobin and DNA adduets after inhalation of C2-C8 1-alkenes (olefins) in the rat, Carcinogenesis (in press).Google Scholar
- Frank, H., Hintze, T. and Remmer, H., 1980, Volatile hydrocarbons in breath, an indication for peroxidative degradation of lipids. In: Kolb, B. (ed.) Applied Headspace Gas Chromatography, Heyden & Son, London, pp. 155–164.Google Scholar
- Hallier, E., Langhof, T., Dannappel, D., Leutbecher, M, Schröder, K., Georgens, H.W., Müller, A. and Bolt, H.M. 1993, Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood: Influence on the induction of sister chromatid exchanges (SCE) in lymphocytes, Arch. Toxicol. 67: 173–178.PubMedCrossRefGoogle Scholar
- ICRP, 1991, 1990 Recommendations of the International Commission on Radiological Protection, ICRP Publication 60, vol. 21, Pergamon Press, Oxford.Google Scholar
- NRC, 1990, National Research Council, Committee on the Biological Effects of Ionizing Radiations, Health effects of exposure to low levels of ionizing radiation, BEIR V Report, Washington, National Academy Press.Google Scholar
- Olsson, U., Lundgren, B., Segura-Aguilar, J., Messing-Eriksson, A., Andersson, K., Becedas, L. and de Pierre J.W., 1992, Effects of selenium deficiency on xenobiotic-metabolizing and other enzymes in rat liver, Internat. J. Vit. Nutr. Res. 63: 27–30Google Scholar
- Segerbäck, D., 1985,In Vivo Dosimetry of Some Alkylating Agents as a Basis for Risk Estimation, Ph.D. Thesis. Stockholm University, Stockholm.Google Scholar
- Törnqvist, M., 1988, Search for unknown adducts: Increase of sensitivity through preselection by biochemical parameters, In: Bartsch, H., Hemminki, K. and O’Neill, I.K. (eds), Methods for Detecting DNA Damaging Agents in Humans: Applications in Cancer Epidemiology and Prevention, International Agency for Research on Cancer, Scientific Publication 89, Lyon, pp. 378–383.Google Scholar
- Törnqvist, M., 1989, Monitoring and Cancer Risk Assessment of Carcinogens Particularly Alkenes in Urban Air, Ph.D. Thesis, Stockholm University, Stockholm.Google Scholar
- Törnqvist, M., 1991, The N-alkyl Edman method for haemoglobin adduct measurement: Updating and applications to humans. In: Garner, R.C., Farmer, P.B., Steel, G.T. and Wright, A.S. (eds), Human Carcinogen Exposure: Biomonitoring and Risk Assessment, Oxford University Press, Oxford, pp. 411–419.Google Scholar